(Q35963698)

11 August 2017

1 reference

title

Immunomodulatory therapy in ophthalmology - is there a place for topical application? (English)

1 reference

11 August 2017

Eckart Bertelmann

1

1 reference

11 August 2017

Uwe Pleyer

series ordinal

2

1 reference

11 August 2017

publication date

1 November 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

218

1 reference

11 August 2017

issue

6

1 reference

11 August 2017

page(s)

359-367

1 reference

Characterisation of the normal conjunctival leukocyte population

11 August 2017

cites work

1 reference

Cyclodextrins in ophthalmic drug delivery

21 January 2018

1 reference

Intraocular availability of topically applied mycophenolate mofetil in rabbits

21 January 2018

1 reference

Transcorneal-paracorneal penetration route for topical application of drugs to the eyt. Mycophenolate mofetil as a model substance

21 January 2018

1 reference

Prolongation of corneal allograft survival with liposome-encapsulated cyclosporine in the rat eye.

21 January 2018

1 reference

Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A.

21 January 2018

1 reference

Corneal allograft rejection: current understanding. 2. Clinical implications

21 January 2018

1 reference

Cyclosporins: immunosuppressive drugs with anti-HIV-1 activity

21 January 2018

1 reference

The use of two immunosuppressive drugs, cyclosporin A and tacrolimus, to inhibit virus replication and apoptosis in cells infected with feline immunodeficiency virus

21 January 2018

1 reference

Placebo-controlled trial of cyclosporin-A in HIV-1 disease: implications for solid organ transplantation

21 January 2018

1 reference

Outcome of penetrating keratoplasty in rheumatoid arthritis.

21 January 2018

1 reference

Long-term effects of topical cyclosporine A treatment after penetrating keratoplasty

21 January 2018

1 reference

Cyclosporine effects on clinical findings and impression cytology specimens in severe vernal keratoconjunctivitis.

21 January 2018

1 reference

Topical cyclosporin A in the management of vernal keratoconjunctivitis

21 January 2018

1 reference

Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group

21 January 2018

1 reference

Tacrolimus (FK506) in the management of high-risk corneal and limbal grafts

21 January 2018

1 reference

Topical liposome-encapsulated FK506 for the treatment of endotoxin-induced uveitis.

21 January 2018

1 reference

FK 506 ointment 0.1 % - A new therapeutic option for atopic blepharitis. Clinical trial with 14 patients

21 January 2018

1 reference

Mycophenolate mofetil. A useful immunosuppressive in inflammatory eye disease.

21 January 2018

1 reference

Immunosuppressive therapy with mycophenolate mofetil (CellCept) in treatment of uveitis

21 January 2018

1 reference

Synergism of RAD and cyclosporin A in prevention of acute rat corneal allograft rejection

21 January 2018

1 reference

Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000080937

1 reference

11 August 2017

1 reference